Sabra Healthcare REIT, Inc. (SBRA) Set to Announce Quarterly Earnings on Tuesday
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) is set to announce its earnings results after the market closes on Tuesday, October 31st.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) opened at 20.95 on Tuesday. The stock has a market cap of $1.37 billion, a PE ratio of 17.63 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a 52 week low of $19.30 and a 52 week high of $29.10. The stock has a 50 day moving average price of $22.01 and a 200 day moving average price of $23.59.
COPYRIGHT VIOLATION WARNING: “Sabra Healthcare REIT, Inc. (SBRA) Set to Announce Quarterly Earnings on Tuesday” was first reported by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/24/sabra-healthcare-reit-inc-sbra-set-to-announce-quarterly-earnings-on-tuesday.html.
SBRA has been the subject of a number of recent research reports. BidaskClub upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a research note on Tuesday, June 27th. Zacks Investment Research upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Tuesday, August 29th. Jefferies Group LLC raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a report on Tuesday, August 15th. Cantor Fitzgerald reissued a “buy” rating and issued a $30.00 price target on shares of Sabra Healthcare REIT in a report on Friday, September 8th. Finally, ValuEngine raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $25.30.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.